1. Home
  2. HSDT

as 04-25-2025 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

Founded: 2014 Country:
United States
United States
Employees: N/A City: NEWTOWN
Market Cap: 1.7M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 79.0K
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -4.33 EPS Growth: N/A
52 Week Low/High: $0.26 - $4.69 Next Earning Date: 05-12-2025
Revenue: $520,000 Revenue Growth: -19.25%
Revenue Growth (this year): 0.04% Revenue Growth (next year): 75.10%

HSDT Daily Stock ML Predictions

Share on Social Networks: